8.30-9.00
Registration
9.00-9.05
Welcome address, Organizing Committee
9.05-9.45
Signaling via receptors for PDGF and TGFbeta - possible targets for tumor treatment,
Carl-Henrik Heldin, Ludwig Institute for Cancer Research, Uppsala
9.45-10.25
Causes and consequences of microRNA dysregulation in cancer
Carlo Croce, Ohio State University, Columbus.
10.25-10.55
COFFEE BREAK
10.55-11.35
TGF-beta signal transduction in breast cancer
Peter ten Dijke, Leiden University, Leiden.
11.35-11.55
PDGF and PDGF receptors in glioma
Monica Nistér, Karolinska Institute, Stockholm.
11.55-12.15
Regulation of cancer progression and drug response by cancer-associated fibroblasts
Arne Östman, Karolinska Institute, Stockholm.
12.15-13.15
LUNCH
13.15-13.55
Cell Signaling by Tyrosine Phosphorylation; From Basic Principles to Cancer Therapy,
Joseph Schlessinger, Yale University School of Medicine, New Haven.
13.55-14.15
Growth factors, angiogenesis and vascular permeability
Christer Betsholtz, Karolinska Institute, Stockholm.
14.15-14.35
Mitochondria, oxidative metabolism and cell transformation
Anna Karlsson, Karolinska Institute, Stockholm.
14.35-15.00
COFFEE BREAK
15.00-15.40
Tumor-promoting functions of TGF-beta in progression of cancer
Kohei Miyazono, University of Tokyo, Tokyo.
15.40-16.20
PDGF and the initiation of non-CIMP gliomagenesis
Eric Holland, Memorial Sloan-Kettering Cancer Center, New York
16.20-16.50
Concluding remarks
Bengt Westermark, Uppsala University, Uppsala.
